Read + Share
Amedeo Smart
Independent Medical Education
Gold R, Piani-Meier D, Kappos L, Bar-Or A, et al. Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study. J Neurol 2022 May 31. pii: 10.1007/s00415-022-11166.PMID: 35639197
Email
LinkedIn
Facebook
Twitter
Privacy Policy